Tocriscreen Kinase Inhibitor 3.0

Pricing Availability   Qty
Description: A bioactive compound library of 210 kinase inhibitors (100 μL 10 mM DMSO solutions) for high-throughput screening, high-content screening, target validation and assay development
Citations (14)
Literature (1)

Biological Activity for Tocriscreen Kinase Inhibitor 3.0

Tocriscreen Kinase Inhibitor 3.0 compound library is a collection of 210 kinase inhibitors supplied pre-dissolved in DMSO (100 μL 10 mM solution). The Tocriscreen Kinase Inhibitor 3.0 Library contains compounds targeting >60 different kinases, including extensive coverage of well-established targets such as VEFGR and AKT, as well as novel targets such as Haspin and DYRK. The Tocriscreen Kinase Inhibitor 3.0 library is suitable for high-throughput screening (HTS), cell based high-content screening (HCS), target validation and assay development. Please view the kinase tree image for a closer look at the pharmacological diversity of this compound library.

If this library does not suit your needs, please submit your requirements through our Tocriscreen PRO custom compound library service.

Scientific Data

Kinase phylogenetic tree illustrating the pharmacological diversity of the Tocriscreen Kinase Inhibitor 3.0 Library. The 210 compounds in the Tocriscreen Kinase Inhibitor 3.0 compound library target over 230 kinases. Targets are evenly spread across all the major IUPHAR kinase subfamilies, with a mix of well-established targets such as VEFGR and AKT, and “dark” kinases such as CDK19 and DYRK1B. To view a larger PDF version of this image, please click on the 'kinase tree' link in the product description.

Chemical diversity of the Tocriscreen Kinase Inhibitor 3.0 compound library. The images show the overlapping chemical space of the 210 compounds in the Tocriscreen Kinase Inhibitor 3.0 compound library (green dots) in relation to the chemical space occupied by the ChEMBL kinase inhibitors (grey dots). Each dot represents a unique fingerprint generated from each compound's 3D molecular structure. The even distribution of the fingerprints of the compounds in the Tocriscreen Kinase Inhibitor 3.0 compound library highlights the chemical diversity of this library.

Key Format and Product Details for Tocriscreen Kinase Inhibitor 3.0

  • 96-well racks with TrakMate tubes & SepraSeal caps
  • Pre-dissolved in DMSO
  • Compounds arranged 80 per rack with 3 racks per library
  • Many compounds are exclusive to Tocris
  • Full chemical and biological data available
  • Exceptional purity
Kinase subfamilies targeted by the Tocriscreen Kinase Inhibitor 3.0 library

Major IUPHAR kinase subfamilies covered by Tocriscreen Kinase Inhibitor 3.0 Library. TK (tyrosine kinase, 29%); CMGC (includes CDK, MAPK, GSK3 and CLK families, 19%); TKL (tyrosine kinase-like, 16%); AGC (includes PKA, PKG and PKC families, 11%); Atypical (7%); CAMK, (calcium/calmodulin-dependent protein kinases, 4%) and Other Kinases (includes CAMKK, CK1 and STE, 14%).

Request Compound List

To request a list of the compounds available in the Tocriscreen Kinase Inhibitor 3.0 please click the request tile below. Compound lists can be provided in Excel or SD format.

Request compound list for Tocriscreen Kinase Inhibitor 3.0

Technical Data for Tocriscreen Kinase Inhibitor 3.0

Storage Store at -20°C

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Tocriscreen Kinase Inhibitor 3.0

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service

References for Tocriscreen Kinase Inhibitor 3.0

References are publications that support the biological activity of the product.

If you know of a relevant reference for Tocriscreen Kinase Inhibitor 3.0, please let us know.

View Related Products by Target

Keywords: Tocriscreen Kinase Inhibitor 3.0, Tocriscreen Kinase Inhibitor 3.0 supplier, tocriscreen, kinase, inhibitor, library, kinases, toolbox, inhibitors, inhibits, compound, libraries, high-throughput, screening, high-content, chemical, biology, applications, Tocriscreen, Compound, Libraries, 7844, Tocris Bioscience

14 Citations for Tocriscreen Kinase Inhibitor 3.0

Citations are publications that use Tocris products. Selected citations for Tocriscreen Kinase Inhibitor 3.0 include:

Orlando et al (2023) Chemical genomics reveals targetable programs of human cancers rooted in pluripotency. Cell Chem.Biol. 30 780 PMID: 37379846

Hewage et al (2020) Chemical manipulation of abscisic acid signaling: a new approach to abiotic and biotic stress management in agriculture. Adv.Sci. 7 2001265 PMID: 32999840

Lee et al (2021) A screen of kinase inhibitors reveals a potential role of Chk1 in regulating Hydra head regeneration and maintenance. Int J Dev Biol 65 523 PMID: 34549798

Wang et al (2019) EGFR-Aurka signaling rescues polarity and regeneration defects in dystrophin-deficient muscle stem cells by increasing asymmetric divisions. Cell Stem Cell 24 419 PMID: 30713094

Moret et al (2019) Cheminformatics tools for analyzing and designing optimized small-molecule collections and libraries. Cell Chem Biol 26 765 PMID: 30956147

Chaudhari et al (2019) Transient c-Src Suppression During Endodermal Commitment of Human Induced Pluripotent Stem Cells Results in Abnormal Profibrotic Cholangiocyte-Like Cells. Stem Cells 37 306 PMID: 30471152

Yang et al (2019) NTRK1 is a positive regulator of YAP oncogenic function. Oncogene 38 2778 PMID: 30542115

Gull et al (2022) Screening of chemical libraries using xenopus embryos and tadpoles for phenotypic drug discovery. Cold Spring Harb.Protoc. 4 PMID: 36180216

Carlson et al (2022) Discovery and characterization of multiple classes of human CatSper blockers. Chem Med Chem 17 e202000499 PMID: 35644882

Jacoby et al (2018) Protocols for the design of kinase-focused compound libraries. Mol.Inform. 37 e1700119 PMID: 29116686

Azad et al (2018) A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun 9 1061 PMID: 29535383

Moeschler et al (2018) 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. Viruses 10 E306 PMID: 29874821

Tomilov et al (2018) Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition. Pharmacol Res 137 89 PMID: 30290222

Markussen et al (2018) GSK3 is a negative regulator of the thermogenic program in brown adipocytes. Sci.Rep. 8 3469 PMID: 29472592

Do you know of a great paper that uses Tocriscreen Kinase Inhibitor 3.0 from Tocris? Please let us know.

Reviews for Tocriscreen Kinase Inhibitor 3.0

There are currently no reviews for this product. Be the first to review Tocriscreen Kinase Inhibitor 3.0 and earn rewards!

Have you used Tocriscreen Kinase Inhibitor 3.0?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Tocriscreen Compound Libraries

Tocriscreen Compound Libraries

This brochure gives an overview of the unique TocriscreenTM bioactive compound library range, including

  • Tocriscreen 2.0 Compound Library
  • Focused Tocriscreen Libraries
  • Tocriscreen FDA-approved Drug Library
  • Tocriscreen PRO Custom Service